| IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway L Wang, T Yi, M Kortylewski, DM Pardoll, D Zeng, H Yu Journal of experimental medicine 206 (7), 1457-1464, 2009 | 1005 | 2009 |
| Recognition of tumors by the innate immune system and natural killer cells A Marcus, BG Gowen, TW Thompson, A Iannello, M Ardolino, W Deng, ... Advances in immunology 122, 91-128, 2014 | 450 | 2014 |
| In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responses M Kortylewski, P Swiderski, A Herrmann, L Wang, C Kowolik, M Kujawski, ... Nature biotechnology 27 (10), 925-932, 2009 | 407 | 2009 |
| Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease T Yi, Y Chen, L Wang, G Du, D Huang, D Zhao, H Johnston, J Young, ... Blood, The Journal of the American Society of Hematology 114 (14), 3101-3112, 2009 | 356 | 2009 |
| A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection W Deng, BG Gowen, L Zhang, L Wang, S Lau, A Iannello, J Xu, TL Rovis, ... Science 348 (6230), 136-139, 2015 | 268 | 2015 |
| Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells M Kato, L Wang, S Putta, M Wang, H Yuan, G Sun, L Lanting, I Todorov, ... Journal of Biological Chemistry 285 (44), 34004-34015, 2010 | 199 | 2010 |
| IL-17 enhances tumor development in carcinogen-induced skin cancer L Wang, T Yi, W Zhang, DM Pardoll, H Yu Cancer research 70 (24), 10112-10120, 2010 | 192 | 2010 |
| Toll-like receptor 9 activation of signal transducer and activator of transcription 3 constrains its agonist-based immunotherapy M Kortylewski, M Kujawski, A Herrmann, C Yang, L Wang, Y Liu, ... Cancer research 69 (6), 2497-2505, 2009 | 153 | 2009 |
| Targeting Stat3 in the myeloid compartment drastically improves the in vivo antitumor functions of adoptively transferred T cells A Herrmann, M Kortylewski, M Kujawski, C Zhang, K Reckamp, ... Cancer research 70 (19), 7455-7464, 2010 | 146 | 2010 |
| FXR Regulates Liver Repair after CCl4-Induced Toxic Injury Z Meng, Y Wang, L Wang, W Jin, N Liu, H Pan, L Liu, L Wagman, ... Molecular endocrinology 24 (5), 886-897, 2010 | 127 | 2010 |
| STAT3 Inhibition Is a Therapeutic Strategy for ABC-like Diffuse Large B-Cell Lymphoma A Scuto, M Kujawski, C Kowolik, L Krymskaya, L Wang, LM Weiss, ... Cancer research 71 (9), 3182, 2011 | 118 | 2011 |
| S1PR1 is an effective target to block STAT3 signaling in activated B cell–like diffuse large B-cell lymphoma Y Liu, J Deng, L Wang, H Lee, B Armstrong, A Scuto, C Kowolik, ... Blood, The Journal of the American Society of Hematology 120 (7), 1458-1465, 2012 | 112 | 2012 |
| S1PR1 is crucial for accumulation of regulatory T cells in tumors via STAT3 SJ Priceman, S Shen, L Wang, J Deng, C Yue, M Kujawski, H Yu Cell reports 6 (6), 992-999, 2014 | 95 | 2014 |
| Host APCs augment in vivo expansion of donor natural regulatory T cells via B7H1/B7. 1 in allogeneic recipients T Yi, X Li, S Yao, L Wang, Y Chen, D Zhao, HF Johnston, JS Young, H Liu, ... The Journal of Immunology 186 (5), 2739-2749, 2011 | 72 | 2011 |
| A selective role of NKG2D in inflammatory and autoimmune diseases N Guerra, K Pestal, T Juarez, J Beck, K Tkach, L Wang, DH Raulet Clinical Immunology 149 (3), 432-439, 2013 | 56 | 2013 |
| Low-dose-rate prostate brachytherapy: 4–8 week postimplant prostate-specific antigen a novel predictor of biochemical failure-free survival CM Callaghan, L Wang, A Alluri, A Lauve, C Boyer, W Russell Brachytherapy 16 (6), 1119-1128, 2017 | 4 | 2017 |
